Skip to content
Disclosery

EXANE DERIVATIVES: MMS position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on MMS, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 0 MMS shares at 2021-12-31 per its 13F-HR filed 2022-01-28.

the latest 13F is the newest step

  1. period ended2021-12-31
    13F 0 shares
    Change vs previous 13F -15,618 shares

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2021-09-30
    13F 15,618 shares
    Change vs previous 13F -4,881 shares

    0.32% of the 13F portfolio, value $1,299,371.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-06-30
    13F 20,499 shares
    Change vs previous 13F +4,532 shares

    0.42% of the 13F portfolio, value $1,809,815.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-03-31
    13F 15,967 shares
    Change vs previous 13F +1,282 shares

    0.43% of the 13F portfolio, value $1,421,639.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2020-12-31
    13F 14,685 shares
    Change vs previous 13F not available

    0.33% of the 13F portfolio, value $1,074,745.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).